Clinical Research, Pharma & Healthcare FinancingOLYMPUS Study Reports 4-Year Response in Urothelial Cancer PatientsBusiness WireApril 28, 2025August 1, 2025 by Business WireApril 28, 2025August 1, 20250157 Data Presented at the 2025 American Urological Association Annual Meeting in Las Vegas, Nevada UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing...
